SE7513641L - Forfarande for framstellning av 6-metyl-8-(substituerade) metylergoliner - Google Patents

Forfarande for framstellning av 6-metyl-8-(substituerade) metylergoliner

Info

Publication number
SE7513641L
SE7513641L SE7513641A SE7513641A SE7513641L SE 7513641 L SE7513641 L SE 7513641L SE 7513641 A SE7513641 A SE 7513641A SE 7513641 A SE7513641 A SE 7513641A SE 7513641 L SE7513641 L SE 7513641L
Authority
SE
Sweden
Prior art keywords
methylergolines
substituted
methyl
procedure
preparation
Prior art date
Application number
SE7513641A
Other languages
English (en)
Other versions
SE421423B (sv
Inventor
E C Kornfeld
N J Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7513641L publication Critical patent/SE7513641L/sv
Publication of SE421423B publication Critical patent/SE421423B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7513641A 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner SE421423B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/530,318 US3985752A (en) 1974-12-06 1974-12-06 6-Methyl-8-(substituted) methylergolines

Publications (2)

Publication Number Publication Date
SE7513641L true SE7513641L (sv) 1976-06-08
SE421423B SE421423B (sv) 1981-12-21

Family

ID=24113213

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7513640A SE421422B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE7513641A SE421423B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-(substituerad metyl) ergoliner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7513640A SE421422B (sv) 1974-12-06 1975-12-03 Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin

Country Status (29)

Country Link
US (1) US3985752A (sv)
JP (2) JPS5946235B2 (sv)
AR (2) AR207664A1 (sv)
AT (2) AT348141B (sv)
AU (1) AU498226B2 (sv)
BE (1) BE836308A (sv)
BG (3) BG33288A3 (sv)
CA (2) CA1062253A (sv)
CH (2) CH617197A5 (sv)
CS (2) CS199609B2 (sv)
DD (2) DD123749A5 (sv)
DE (1) DE2554000A1 (sv)
DK (2) DK142321B (sv)
ES (3) ES443276A1 (sv)
FR (1) FR2293203A1 (sv)
GB (1) GB1526835A (sv)
GR (2) GR60026B (sv)
HU (3) HU175228B (sv)
IE (1) IE42372B1 (sv)
IL (1) IL48573A (sv)
MX (1) MX3113E (sv)
NL (1) NL7514058A (sv)
PH (1) PH12630A (sv)
PL (3) PL102195B1 (sv)
RO (2) RO65456A (sv)
SE (2) SE421422B (sv)
SU (3) SU685155A3 (sv)
YU (2) YU304775A (sv)
ZA (1) ZA757624B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
HU180467B (en) * 1979-07-12 1983-03-28 Gyogyszerkutato Intezet Process for producing new ergol-8-ene- and ergoline-sceleted compounds
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
JPH0541005Y2 (sv) * 1987-07-14 1993-10-18
JPH02174820A (ja) * 1988-12-27 1990-07-06 Sekisui Chem Co Ltd トイレット
WO2000054776A1 (en) * 1999-03-17 2000-09-21 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695752C3 (de) * 1966-07-29 1974-06-06 Societa Farmaceutici Italia, Mailand (Italien) 1 ,ö-Dimethyl-ebeta-N-carbobenzoxyaminomethyl-2,3-dihydro-1 Oalpha-ergolin und ein Verfahren zu seiner Herstellung
CH507248A (de) * 1967-03-16 1971-05-15 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von D-6-Methylergolin(I)ylessigsäure

Also Published As

Publication number Publication date
YU304875A (en) 1982-02-28
DD123749A5 (sv) 1977-01-12
BG33435A3 (en) 1983-02-15
FR2293203B1 (sv) 1978-07-28
GB1526835A (en) 1978-10-04
HU175228B (hu) 1980-06-28
FR2293203A1 (fr) 1976-07-02
ES443275A1 (es) 1977-09-16
HU173847B (hu) 1979-09-28
CS200483B2 (en) 1980-09-15
PL102195B1 (pl) 1979-03-31
USB530318I5 (sv) 1976-01-13
SU685155A3 (ru) 1979-09-05
BG33288A3 (en) 1983-01-14
SE7513640L (sv) 1976-06-08
BG33287A3 (en) 1983-01-14
CH619465A5 (sv) 1980-09-30
MX3113E (es) 1980-04-18
DK547575A (sv) 1976-06-07
IL48573A (en) 1979-03-12
NL7514058A (nl) 1976-06-09
CA1062253A (en) 1979-09-11
CS199609B2 (en) 1980-07-31
DK547675A (da) 1976-06-07
BE836308A (fr) 1976-06-08
DK142321C (sv) 1981-03-09
HU173724B (hu) 1979-07-28
DD123748A5 (sv) 1977-01-12
JPS5182300A (sv) 1976-07-19
DE2554000A1 (de) 1976-06-16
AR208104A1 (es) 1976-11-30
YU304775A (en) 1982-02-28
IE42372B1 (en) 1980-07-30
ATA927975A (de) 1978-04-15
JPS59210085A (ja) 1984-11-28
ES443276A1 (es) 1977-08-16
AT347050B (de) 1978-12-11
CA1062252A (en) 1979-09-11
AT348141B (de) 1979-01-25
SE421423B (sv) 1981-12-21
ZA757624B (en) 1977-07-27
US3985752A (en) 1976-10-12
IL48573A0 (en) 1976-01-30
GR60026B (en) 1978-03-31
GR60025B (en) 1978-03-31
SE421422B (sv) 1981-12-21
AU8718275A (en) 1977-06-09
IE42372L (en) 1976-06-06
DK142321B (da) 1980-10-13
JPS5946235B2 (ja) 1984-11-10
ES457709A1 (es) 1978-03-01
PL106884B1 (pl) 1980-01-31
AR207664A1 (es) 1976-10-22
PH12630A (en) 1979-07-05
CH617197A5 (sv) 1980-05-14
RO65456A (ro) 1980-01-15
RO64281A (fr) 1979-07-15
PL102198B1 (pl) 1979-03-31
SU724085A3 (ru) 1980-03-25
ATA927875A (de) 1978-06-15
SU694075A3 (ru) 1979-10-25
AU498226B2 (en) 1979-02-22
JPS6017795B2 (ja) 1985-05-07

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7513085L (sv) Forfarande for framstellning av etrar
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE413407B (sv) Forfarande for framstellning av n?726-substituerade adeniner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7513641L (sv) Forfarande for framstellning av 6-metyl-8-(substituerade) metylergoliner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
AR203678A1 (es) Procedimiento de preparacion de 2-cetoglutarato de vincamina
SE7507482L (sv) Forfarande for framstellning av substituerade l-sulfonylbensimidazoler.
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
SE7605427L (sv) Forfarande for framstellning av klorcyan
NO149427C (no) Fremgangsmaate for fremstilling av fenyl- henholdsvis naftyl-uretaner.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7513641-6

Effective date: 19880923

Format of ref document f/p: F